CAP-PIRO评分系统在预测社区肺炎的预后和严重程度方面的表现:单一中心前性研究
Xiangqun Zhang1,2, Long Yang1,3, Junyuan Wu1,3
1Emergency Medicine Clinical Research Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China.
CAP-PIRO评分有效预测社区获得的严重肺炎 (CAP) 结果,包括ARDS和死亡率. 将CAP-PIRO与乳酸水平相结合,进一步提高了危急疾病的预测准确性.
科学领域:
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
- 临床流行病学 临床流行病学
背景情况:
- 社区获得性肺炎 (CAP) 是一个重大的全球健康挑战,患病率和死亡率高.
- 现有的严重性评分系统难以准确预测患者的结果.
- CAP-PIRO (倾向,侮辱,反应和器官功能障碍) 系统提供了一种全面的方法来评估CAP的严重程度和预后.
研究的目的:
- 评估CAP-PIRO评分系统在预测CAP患者的预后和严重程度方面的有效性.
- 评估CAP-PIRO对预测急性呼吸困扰综合征 (ARDS) 发展和28天死亡率的能力.
- 将CAP-PIRO的预测性能与CURB-65和PSI等既有得分进行比较.
主要方法:
- 预计将从急诊室招收875名CAP患者.
- 在入院后6小时内收集临床和实验室数据.
- 计算和比较CAP-PIRO,CURB-65和PSI得分;按ARDS分层,死亡率和氧化水平进行分层.
主要成果:
- CAP-PIRO和乳酸水平是ARDS和28天死亡率的独立预测指标.
- 与CURB-65和PSI (更高的AUC) 相比,CAP-PIRO在28天死亡率方面的预测准确度更高.
- CAP-PIRO和乳酸的组合显著改善了ARDS预测的准确性.
结论:
- CAP-PIRO评分系统显示了对CAP不利结果的强大预测能力.
- 将CAP-PIRO与乳酸结合起来,可以提高危急疾病的预测能力.
- 在社区获得性肺炎患者的临床风险分层中,CAP-PIRO具有价值.
更多相关视频
12:27The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 2, 2014
02:28Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
相关概念视频
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Receiver Operating Characteristic Plot
